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Purine Metabolism During Strenuous Muscular 
Exercise in Man 
John R. Sutton, Cornelius J. Toews, Graham R. Ward, and Irving H. Fox 
This study was designed to examine the influence of 
exercise on purine metabolism in man. In 15 men, 
the plasma uric acid concentration increased from 
6.9 to 8.5 mg/dl following a 5000-m race and from 
6.2 to 7.9 mg/dl in 11 men following a 42-km 
marathon. During a progressive exercise test on a 
cycle ergometer, the plasma uric acid concentration 
did not change significantly in 11 subjects. However, 
the plasma oxypurines increased from 19 uM at rest 
to 50 pM at exhaustion and the urinary excretion of 
oxypurines increased from 14.0 to 400 pmol/g cre- 
atinine. Intracellular ATP decreased from 5.17 to 
2.91 pmol/g and ADP and AMP increased from 0.85 
to 1.29 and from 0.12 to 0.15 pmol/g wet weight, 
respectively. These observations suggest that there 
is an accelerated degradation of purine nucleotides 
to the precursors of uric acid in skeletal muscle 
during vigorous exercise. 
T 0 ELUCIDATE the biochemical basis for the regulation of metabolic pathways in 
normal and disease states in man, it is often 
necessary to study a model manipulated to its 
extremes of function. The understanding of 
human purine metabolism has developed in this 
manner. The major milestones were achieved by 
the discovery of inherited disorders and drugs 
that modify normal biochemical control mecha- 
nisms.‘-’ 
As strenuous exercise increases the plasma 
uric acid&’ and plasma oxypurines” concentra- 
tions, it may also provide a physiologic model to 
study the normal regulation of purine metabo- 
lism. 
The present study was performed to examine 
the regulation of purine metabolism during exer- 
cise using the xanthine oxidase inhibitor, allopu- 
rinol. We demonstrate that exercise alters body 
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purine metabolism by increasing the rate of 
oxypurine formation. The source of the oxypu- 
rines is not clear, but arguments are presented 
which suggest that they may be derived from 
muscle adenine nucleotides. 
MATERIALS AND METHODS 
Exercise Procedures 
Four studies were conducted on normal, healthy men to 
whom the nature and risks of the experiments were explained 
and who then gave informed consent, Studies I and 2 were 
conducted during athletic competition, whereas studies 3 and 
4 were conducted in a laboratory. using a cycle ergometer. 
Study 1. Venous blood was collected before and immedi- 
ately after the completion of a 5000 meter race in a veterans’ 
athletic meet. Samples were obtained in 15 healthy men 
whose mean age was 49 years (36-67 yr). 
Study 2. In I I subjects, mean age 32 years (20-67 yr). 
venous blood was obtained just prior to and within three 
minutes of completing a 42 km marathon race. 
Study 3. A maximum progressive cycle ergometer test” 
was performed in 11 normal men, mean age 30 years (22-42 
yr). Venous blood samples were obtained at rest, following a 
12-hour overnight fast, at exhaustion, and at 30 minutes 
following exercise. The exercise was started at 100 kpm/min 
and was increased by 100 kpm/min each minute until 
exhaustion. The heart rate was monitored continuously by a 
V, bipolar electrode and recorded at minute intervals. 
Study 4. The subjects in Study 3 were restudied as 
previously outlined, except that the subjects took allopurinol 
orally, 200 mg every 6 hours for two days. The last dose of 
allopurinol was taken two hours prior to the exercise study. 
In all the studies, the venous blood was collected in 
heparinized tubes and stored on ice until centrifuged. The 
plasma was stored at -2OOC until analyzed. In studies 3 and 
4, where urine samples were analyzed, collections were made 
over a 45-minute period before exercise and over a further 30 
minutes, which included the exercise period. The samples 
were stored at -20°C until analyzed. In eight subjects, 
needle muscle biopsies were obtained from the vastus later- 
alis group at rest and at exhaustion.12 The biopsies were 
frozen in liquid nitrogen within two seconds of sampling and 
stored in liquid nitrogen until analyzed. Muscle biopsies were 
only taken in the control study, ie without allopurinol. 
Analytical Techniques 
Uricase, xanthine oxidase. and purine nucleoside phospho- 
rylase in 3.0 M ammonium sulfate were obtained from 
Sigma Chemical Co., St. Louis, MO. All chemicals utilized 
were of the highest quality available commercially. Uric acid 
was determined by the uricase method.” Urine creatinine 
was determined as previously describedI and the urine 
oxypurines were determined using enzymatic spectropho- 
tometric methods.” The relative quantity of urine hypoxan- 
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Table 1. Biochemical Effects of Races 
Uw treat- 
Na’ K’ Cl HCO, urea ACld ,n,ne PO4 Ca” Mg” Album,” SOOT CPK 
(mMl ImMI (mMl (mMI Imgldll Imgldll Imaldl) Imgldll Imgidll (mgidll Ig/dll IrU/ml/m~nl ,JlUiml,rn,n, 
5000 Meter Race 











145 4.1 101 29 27.2 6.9 1.0 3.2 
1 0.1 1 1 1 0.2 0.0 0.1 
141t 39t 1039 149 27 4’ 8.45 1.55 4.89 
1 0.1 1 1 1 0.2 01 0.2 
143.4 4.0 102.4 28.2 33.4 6.2 1 .o 4.1 
0.8 0.1 0.8 0.6 1.7 0.4 0.04 0.4 
147.65 4.45 102.4’ 26.4$ 46.66 7.95 1.27 4.5’ 
0.9 0.1 1 .o 0.5 3.4 0.3 0.1 0.2 
5.4 _ _ 
- 0.1 
- 5.4’ _ 
_ _ 01 . . 
10.0 2 0 5.5 9.8 72 
01 0.1 01 0.8 15 
9.65 2.0’ 6.25 14.99 1955 
0.1 0.1 0.1 1.3 44 
$,n,f,cance of r test: *, not slgnlfant: t, p < 0.05; $p < 0.025; 5, < 0.01 
thine and xanthine were determined by differential spectros- 
copy (H. Fraser and I.H. Fox. unpublished method). Plasma 
oxypurine concentrations were determined by using a modifi- 
cation of the urinary oxypurine method.” Plasma protein 
was precipitated with one volume of 3.0 M perchloric acid. 
The protein was removed by centrifugation and the superna- 
tant brought to pH 4 to 5 with 4.0 N KOH. The neutralized 
plasma protein-free extract was incubated in 0.07 M sodium 
pyrophosphate, pH 8.0 with uricase (2.4 IU/ml buffer) for 
I8 hours. The reaction was stopped by the addition of 0.25 
ml of 4.0 N NaOH. Finally. HCI was added to bring the pH 
to 8.0 and the oxypurines were assayed as outlined previous- 
ly.” The assay was linear up to 90 PM and recoveries of 83% 
were obtained when known quantities of hypoxanthine were 
added. 
Urine inosine concentration was determined by a modifi- 
cation of the method outlined for plasma oxypurines. The 
inosine was converted to uric acid by incubating the perchlor- 
ic-neutralized extract with 0.6 IU of nucleoside phosphory- 
lase and 0.12 IU of xanthine oxidase in SO mM sodium 
phosphate butfer, pH 8.0 for 30 minutes. The uric acid 
concentration was then determined using the uricase meth- 
od” with appropriate controls to determine the uric acid 
concentration before determination of the inosine concentra- 
tion. 
Skeletal muscle ATP, ADP, and AMP were measured 
using enzymatic fluorometric methods.” Plasma lactate was 
measured similarly.” Other biochemical variables were 
measured using standard techniques (Table I). 
RESULTS 
Studies I and 2 
The serum uric acid concentration increased 
from 6.9 mg/dl at rest to 8.4 mg/dl following the 
5000 meter race (p ~0.01) and from 6.2 mg/dl 
to 7.9 mg/dl during the marathon (p ~0.01, 
Table 1). The basis for the elevated serum uric 
acid was unclear from these studies. There were 
other changes in the plasma biochemical data 
during the races, but none of these could directly 
provide a mechanism for the observed increase in 
the plasma uric acid concentration following the 
races (Table 1). 
Studies 3 and 4 
There was no difference in exercise perfor- 
mance with or without allopurinol. The values 
for maximum heart rate was 184 on each occa- 
sion, the maximum power output was 1590 and 
1580 kpm and the plasma lactate values at 
exhaustion were 6.7 and 6.6 mM respectively 
(Table 2). 
Uric acid production was assessed by measur- 
ing changes in plasma and urine uric acid, 
oxypurines, and inosine concentrations. An 
increase in the accumulation of these metabo- 
lites was interpreted as an acceleration of the 
pathways responsible for the formation of uric 
acid. 
During exercise, the following alterations 
were observed: (1) the mean plasma uric acid did 
not change (Table 2); (2) the urine uric acid 
diminished from a mean value of 0.45 to 0.36 
mg/mg creatinine (Table 3), a 20% decrease 
which was not statistically significant, and the 
uric acid clearances were similarly reduced: (3) 
the mean plasma oxypurine concentration 
increased from a mean value of 19 PM to 35 @M 
(p ~0.10) immediately after exercise and then 
to 50 PM (p ~0.01) after the rest period (Table 
2); (4) the mean urinary oxypurine (Table 3) 
increased from 0.14 to 0.40 pmol/mg creatinine. 
a 195% increase (p t0.02), which was 
completely related to an increase of hypoxan- 
thine excretion and accompanied by a 73% 
increase in the ratio of the oxypurine clearance 
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Table 2. Effect of Allopurinol on Work Capacity. Maximum Heart Rate, Plasma Lactate, 
Plasma Uric Acid and Plasma Oxypurine Concentrations 
Rest 
COlltd 
Exhaustion PostexercIse Rest PostexercIse 
Maximum Power Output 
(kpm/min) 




Plasma Uric Acid 
(mg/dl) 
Plasma Oxypurines 
(p mole) (n = 7) 
1590 * 100 1578k 111 
184? 6 184 & 5 
0.88 ? 0.8 6.6 + 0.8 1.2 i 0.2 6.7 & 0.4 
6.2 * 0.3 6.2 k 0.2 6.3 * 0.3 3.7 + 0.2 3.8 t 0.2 3.7 * 0.3 
19.0 t 2.0 35.3 * 7.0 50.4 t 4.0 18.3 + 4.0 59.0 +_ 9.0 82.7 + 10.0 
Mean + 1 SEM. (n = 11). 
to the creatinine clearance; (5) no adenosine was 
detected in the urine, but an increase in urinary 
inosine was noted in 4 of 5 subjects following 
exercise (Table 4); and (6) the mean serum 
creatinine was 0.83 * 0.03 (SEM) before and 
0.93 + 0.02 (SEM) mg/dl during the exercise 
period. 
Allopurinol was used to block xanthine 
oxidase in an effort to diminish exercise effects 
on uric acid and magnify changes in oxypurines. 
The latter was only partially successful since 
only minimal, if any, changes were observed in 
plasma uric acid during the cycle ergometer 
exercise test, although basal levels decreased 
from 6.2 + 0.3 to 3.7 + 0.2 mg/dl (p ~0.01). 
During the exercise with allopurinol, the follow- 
ing were observed: ( 1) the mean plasma uric acid 
of 3.7 mg/dl did not change (Table 2); (2) the 
mean urinary uric acid decreased from 0.20 to 
0.18 mg/mg creatinine (Table 3), a 9% diminu- 
tion which was not statistically significant, and 
the uric acid clearance was similarly reduced; 
(3) the mean plasma oxypurine increased from 
18 PM to 59 PM (p ~0.02) immediately after 
exercise and then to 83 &l (p ~0.01) after the 
recovery period (Table 2); and (4) the mean 
urinary oxypurine increased from 0.95 to 1.01 
pmol/mg creatinine (Table 3), an insignificant 
change. Estimates of the ratio of the oxypurine 
clearance to the creatinine clearance indicated a 
diminution of 64% during exercise, suggesting 
that the lack of an increase in urine oxypurines 
was related to a decreased oxypurine clearance. 
These data demonstrate an increased pro- 
duction of uric acid precursors which could even- 
tually lead to a rise in uric acid synthesis. A 
potential source for these increased purine cata- 
bolic intermediates was sought in the adenine 
nucleotide content of the exercising skeletal 
muscle (Table 5). Exercise decreased the muscle 
ATP concentration from 5.17 to 2.91 pmol/g 
wet weight (p <O.OOl) and ADP increased from 
0.85 to 1.29 pmol/g (p ~0.01) while AMP 
concentrations did not change. Total adenine 
nucleotides decreased from a mean value of 6.14 
to 4.35 pmol/g wet weight (p ~0.01). 
DISCUSSION 
Vigorous muscular exercise has been pre- 
viously recognized as a cause of hyperurice- 
mia.“’ Although the exact basis for this eleva- 
tion of the serum uric acid has remained unclear, 
it appears that more severe and prolonged forms 
of exertion are related to greater increases in this 










(fi mole/mg creatinine) 
0.45 + 0.09 0.36 + 0.12 0.20 + 0.05 0.18 + 0.05 
12.81 + 0.56) (2.25 ? 0.75) (1.25 + 0.31) 11.13 + 0.31) 
0.14 + 0.07 0.40 * 0.10 0.95 -+ 0.08 1.01 + 0.09 
Mean r 1 SEM. 
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Table 4. Urinary lnosine Excretion During Exercise 
Urinary lnosine 
lp mok/mg creatinind 
Subject 
1 3.9 96.0 
2 1.2 39.0 
3 1.6 1.4 
4 14.5 39.0 
5 2.2 9.0 
Mean 4.7 36.9 
SEM 2.5 16.6 
p, not significant 
ll=5 
purine end-product. In extreme cases, abnormal- 
ities of uric acid metabolism have been impli- 
cated in the etiology of heat stress nephropa- 
thy18,19 and in the acute renal failure following 
prolonged epileptic seizures.20 In our study, the 
shorter duration of the progressive cycle ergom- 
eter test did not cause hyperuricemia, whereas 
the longer periods of exertion of a 5000 meter 
race and a 42 kilometer marathon were asso- 
ciated with uric acid increases of 1.5 and 1.7 
mg/dl respectively (Table 1). The failure to 
demonstrate any increase in plasma uric acid 
was probably related to exercise intensity or 
duration, as only the last 3 to 4 minutes of a 
progressive exercise test are at high intensities. 
The importance of exercise intensity is 
confirmed by more recent work from this labora- 
tory in which 20 minutes of exercise at 70% VO, 
max consistently elevated plasma uric acid, 
whereas 20 minutes at 35% V02 max did not 
(Sutton, J.R., 1979, unpublished). 
Elevations of the serum uric acid may result 
from a decreased renal excretion of uric acid, an 
increased synthesis of uric acid, or a combination 
of these two factors. Decreased renal clearance 
of uric acid during the period of vigorous exer- 
cise has been demonstrated by Nichols et aL6 
Table 5. Effect of Exercise on Skeletal Muscle Adenine 
Nucleotides in 8 Subjects 
Control Exercise 
(p mole/g wet weight) 
ATP 5.17 * 0.7 2.91 +- 0.q 
ADP 0.85 t 0.1 1.29 * O.l$ 
AMP 0.12 * 0.03 0.15 * 0.03’ 
Total Adenine 
Nucleotides 6.14 ? 0.8 4.35 + 0.6t 
Significance of t test: *not significant: tp < 0.001: tp < 
0.01. (Mean ? 1 SEMI 
and a modest, but not significant, diminution of 
uric acid excretion was observed during the cycle 
ergometer test (Table 3). The factors that may 
account for this decrease of uric acid clearance 
include hypohydration,” contracted extracellu- 
lar volume, 22 increased formation of angioten- 
sin,23 and hyperlacticacidemia.‘4 However, not 
all previous observations can be explained by 
decreased urate excretion. Although hyperlacti- 
cacidemia is known to decrease the renal clear- 
ance of uric acid, hyperuricemia is not produced 
during short intervals2’ and was not evident 
following the cycle ergometer study (Table 1). 
Fox et al.” infused sodium lactate in large quan- 
tities over a two-hour period and found a mark- 
edly diminished fractional clearance of uric acid 
without any change in the serum uric acid. 
Hyperuricemia and hyperlacticacidemia had 
been observed immediately after severe exercise, 
but hyperuricemia alone persisted after 12 
hours.” Furthermore, uric acid was elevated out 
of proportion to blood urea following prolonged 
epileptic seizures.” Thus, not all previous obser- 
vations can be appropriately explained by 
decreased urate excretion. 
There is direct evidence to support the possi- 
bility that increased uric acid synthesis accom- 
panies exercise. During periods of vigorous mili- 
tary training, both the serum and urinary uric 
acid were observed to increase.‘X.26 An elevation 
of urinary oxypurines, mainly hypoxanthine, has 
been found in subjects exercising until exhaus- 
tion.” The maximum progressive exercise test on 
a cycle ergometer did not cause hyperuricemia in 
spite of hyperlacticacidemia, but resulted in an 
elevation of plasma oxypurines, and urinary 
oxypurines and inosine. The increase of these 
precursors of uric acid in the plasma and urine of 
exercising subjects suggests an activation of the 
purine catabolic pathways leading to uric acid.” 
Exercising human skeletal muscle has de- 
creased ATP and creatine phosphate concentra- 
tions.‘6.28 The degree of high energy phosphate 
depletion appears to be related to the amount 
and duration of the power output. The maximum 
decrease described for ATP with exhaustion has 
been to 60% of the control values, while signifi- 
cant depletions to 81% of controls were found at 
1200 kpm/min.16 In our study, muscle ATP 
concentrations decreased to 56% of the control 
values with the maximum power of 1600 
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kpm/min. Exercise in humans has also been 
accompanied by elevated peripheral venous uric 
acid and oxypurines, and urinary oxypurines and 
inosine (Table 1 ).‘34.537.9 
Although our exercise studies do not prove the 
source of these increased catabolic intermediates 
in the peripheral venous blood and urine, stoi- 
chiometric considerations suggest that exercis- 
ing muscle may be the source of the purine 
intermediates. During the cycle ergometer test, 
plasma oxypurines increased by 65 puM (18 to 83 
palm) on allopurinol therapy or by 3 1 PM (19 to 
50 PM) without allopurinol. If it is assumed that 
oxypurines can be distributed in total body 
water, then this could represent 2600 pmoles of 
oxypurines with allopurinol therapy or 1240 
pmoles without allopurinol at one point in time. 
However, these calculations may only represent 
a fraction of the total oxypurine turnover. It is 
more likely that there is active production of 
hypoxanthine and reutilization of this compound 
to form IMP by hypoxanthine-guanine phospho- 
ribosyltransferase. The reutilization of hypoxan- 
thine is highly efficient, since in the absence of 
hypoxanthine-guanine phosphoribosyltransfer- 
ase, there is a massive increase in purine excre- 
tion, which results in part from an inability to 
reutilize hypoxanthine.’ The efficiency of reutili- 
zation is reflected in part by the urinary excre- 
tion of only 100 to 200 pmoles of oxypurine at 
the most during cycle ergometry. The decrease 
of muscle adenine nucleotides observed can more 
than account for this quantity of oxypurine 
formation. In a 70-kg man exercising 30 kg of 
muscle, ATP decreased by 2.3 pmol/g for a total 
69,000 pmol reduction of ATP. Although the 
liver could generate substantial quantities of 
oxypurines from adenine nucleotides, it seems 
less likely to account for the changes observed. 
Since total adenine nucleotide concentration is 
2.5 pmol/g of liver, ” a 50% decrease of adenine 
nucleotide concentration would only generate 
about 1900 pmoles of oxypurine (assuming a 
liver weight of 1500 g). 
intracellular ATP levels and concomitant 
increased concentrations of AMP and possible 
IMP could lead to the activation of the nucleo- 
tide dephosphorylation reaction and accelerate 
purine nucleotide degradation to the catabolic 















+ URIC ACID 
There is a known relationship between 
decreased intracellular ATP concentrations, 
increased AMP concentrations, and activation of 
purine nucleotide catabolism. ATP inhibits the 
activity of 5’-nucleotidase and alkaline phospha- 
tase and the k, for AMP is in the range of known 
physiologic concentrations.29 The diminution of 
Fig. 1 Postulated effects of exercise on human purine 
ribonucleotide catabolism. In muscle tissue, ATP may be 
converted to ADP by myosin ATPase (3) during exercise. 
The ADP generated may be converted to ATP by creatina- 
phosphokinase (1). the mitochondrial electron transport 
system (2). glycolysis (2). and by adenylate kinase (4). As 
ATP decreases, there is a buildup of AMP and IMP, with the 
latter being formed by adenylate deaminese (5). The 
increase of IMP and AMP and the decrease of ATP activate 
dephosphorylation by 5’-phosphomonoesterases (61. There 
ensues a cascade of nucleotide degradation to Purina 
catabolic intermediates. AMP or IMP are dephosphorylated 
by nonspecific phosphatase or 5’-nucleotidase (6). Adano- 
sine deaminase (7) degrades adenosine to inosina. lnosine 
is degraded to hypoxanthine by purine nucleoside phos- 
phorylase (8). Hypoxanthina is converted to xanthine and 
xanthine is converted to uric acid by xenthine oxidasa (9). a 
reaction which allopurinol inhibits. Oxypurines refer to 
hypoxanthine and xanthine together. The dotted line indi- 
cates inhibition of (6) by ATP. The arrows show changes 
related to muscular exercise with increase (?I end 
decrease (1). The numbers above in the text indicate 
enzyme reactions. 
PURINE METABOLISM IN EXERCISE 
intermediates.*’ The elevation of plasma creatine 
phosphokinase following exercise would also 
support muscle as the site of origin of the purine 
nucleotides. 
An alternative mechanism to account for the 
exercise-induced increase of purine degradation 
products is the activation of purine biosynthesis 
de novo. Although the acute diminution of 
muscle nucleotides would not support this as a 
primary mechanism, it is likely that such an 
increase of purine biosynthesis could occur in 
response to the diminution of intracellular 
259 
nucleotides.‘” This secondary mechanism has 
been proposed to explain the elevation of purine 
synthesis accompanying fructose-induced hy- 
peruricemia.3’m34 
Thus, studies of purine metabolism in vigorous 
muscular exercise suggest a complicated regula- 
tory mechanism dependent upon changes in the 
intracellular nucfeotide environment. Physio- 
logic alteration of this system, initiated by 
decreases of ATP concentrations, could be a 
factor leading to the nucleotide catabolism 
observed (Fig. 1). 
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